{"id":"W4407701540","doi":"10.1200/jco.2025.43.5_suppl.tps889","title":"A phase 2/3 multicenter trial evaluating safety and efficacy of a new mucoadhesive gemcitabine suspension for ablation of upper tract urothelial carcinoma.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Gemcitabine; Urothelial carcinoma; Multicenter study; Oncology; Carcinoma; Urology; Internal medicine; Chemotherapy; Bladder cancer; Cancer; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002371044,0.00177224,0.001685882,0.0005144186,0.0003898425,0.001049411,0.001058988,0.001717457,0.005493428],"category_scores_gemma":[0.001446855,0.0006625715,0.001421724,0.0004165509,0.00107994,0.001101212,0.0004627313,0.003186466,0.001246174],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007178704,"about_ca_system_score_gemma":0.001655426,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000646519,"about_ca_topic_score_gemma":0.001262902,"domain_scores_codex":[0.9994061,0.0003212328,0.00002988303,0.000098007,0.00004808179,0.00009665157],"domain_scores_gemma":[0.9990659,0.0001642909,0.0002386792,0.00008102943,0.00006453333,0.0003854992],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9061882,0.0291921,0.002159032,0.0007776616,0.0007350817,0.0001537577,0.0001482343,0.001034015,0.01841135,0.0001808009,0.002242367,0.03877736],"study_design_scores_gemma":[0.7406303,0.2531863,0.002687826,0.00002460891,0.0002526659,0.0001100141,0.00002508832,0.0005837595,0.001411032,0.00009601967,0.0009765369,0.00001581061],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9865455,0.002069507,0.000904432,0.000684938,0.0002217203,0.006161415,0.001581835,0.0001884282,0.001642189],"genre_scores_gemma":[0.9813821,0.001591737,0.003016345,0.001232661,0.0002464015,0.00706809,0.002862481,0.0000544933,0.002545699],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005493428,"threshold_uncertainty_score":0.01837736,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1555843798926918,"score_gpt":0.521490643124918,"score_spread":0.3659062632322262,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}